- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 513/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 513/04
Total number of patents in this class: 3933
10-year publication summary
|
290
|
250
|
265
|
306
|
328
|
306
|
299
|
283
|
284
|
86
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
95 |
| Merck Patent GmbH | 5909 |
79 |
| F. Hoffmann-La Roche AG | 7958 |
76 |
| Boehringer Ingelheim International GmbH | 4629 |
62 |
| Janssen Pharmaceutica N.V. | 3839 |
62 |
| Takeda Pharmaceutical Company Limited | 2961 |
60 |
| Merck Sharp & Dohme LLC | 3689 |
60 |
| Hoffmann-La Roche Inc. | 3060 |
57 |
| Genentech, Inc. | 3742 |
50 |
| Novartis AG | 11238 |
49 |
| Daiichi Sankyo Company, Limited | 1829 |
49 |
| Achillion Pharmaceuticals, Inc. | 176 |
48 |
| BASF SE | 19740 |
45 |
| Amgen Inc. | 3779 |
40 |
| Incyte Corporation | 918 |
36 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
34 |
| Sumitomo Chemical Company, Limited | 8808 |
32 |
| Gilead Sciences, Inc. | 1879 |
32 |
| Vertex Pharmaceuticals Incorporated | 1581 |
29 |
| AstraZeneca AB | 3042 |
28 |
| Other owners | 2910 |